Purus Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-300
| Closed | -$214K | – | 123 |
|
|
2024
Q4 | $214K | Hold |
300
| – | – | 0.08% | 114 |
|
|
2024
Q3 | $315K | Hold |
300
| – | – | 0.13% | 89 |
|
|
2024
Q2 | $315K | Hold |
300
| – | – | 0.14% | 87 |
|
|
2024
Q1 | $289K | Hold |
300
| – | – | 0.14% | 90 |
|
|
2023
Q4 | $263K | Hold |
300
| – | – | 0.15% | 104 |
|
|
2023
Q3 | $247K | Hold |
300
| – | – | 0.17% | 100 |
|
|
2023
Q2 | $216K | Hold |
300
| – | – | 0.14% | 113 |
|
|
2023
Q1 | $247K | Hold |
300
| – | – | 0.19% | 101 |
|
|
2022
Q4 | $216K | Hold |
300
| – | – | 0.2% | 102 |
|
|
2022
Q3 | $207K | Buy |
+300
| New | +$207K | 0.19% | 99 |
|
|
2022
Q2 | – | Sell |
-300
| Closed | -$210K | – | 108 |
|
|
2022
Q1 | $210K | Buy |
+300
| New | +$210K | 0.15% | 108 |
|